My Baby Biome: Infant Stool Samples for Microbiome Health (MBB)
NCT ID: NCT05472688
Last Updated: 2024-04-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
430 participants
OBSERVATIONAL
2022-07-14
2029-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluating the Impact of Synbiotic Supplementation on Infants and Toddlers
NCT06746285
Gut Microbiome Associated Study of Shanghai Infants With Jaundice
NCT03510936
Maternal & Offspring Microbiome Study
NCT05123612
Probiotic Supplementation in Breastfed Newborn Infants
NCT02286999
Infant Microbiota and Probiotic Intake Study
NCT02457338
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Exclusion Criteria
* Infants given any antibiotic or probiotic treatments
* Infants delivered prematurely or admitted to the NICU outside of establishment of normal feeding
* Infants with mothers under the age of 18
* Infants with mothers known to have HIV, Hepatitis A, Hepatitis B, Hepatitis C, or SARS-CoV2
0 Months
2 Months
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Persephone Biosciences
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Persephone Biosciences, Inc.
San Diego, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Persephone Biosciences Website
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PB-2022-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.